Mackay Shields LLC Invitae Corp Transaction History

Mackay Shields LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $1.1 Million - $1.71 Million	-42,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $819,888 - $1.41 Million	-24,800 Reduced 36.96%	42,300 $1.62 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $500,352 - $734,720	-12,800 Reduced 16.02%	67,100 $2.81 Million
Q3 2020 Nov 04, 2020	SELL	$28.43 - $44.67 $744,866 - $1.17 Million	-26,200 Reduced 24.69%	79,900 $3.46 Million
Q2 2020 Jul 31, 2020	BUY	$11.71 - $30.29 $1.03 Million - $2.66 Million	87,700 Added 476.63%	106,100 $3.21 Million

Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $433,952 - $1.56 Million	-56,800 Reduced 75.53%	18,400 $251,000
Q4 2019 Feb 11, 2020	BUY	$15.02 - $20.57 $114,152 - $156,332	7,600 Added 11.24%	75,200 $1.21 Million
Q3 2019 Nov 01, 2019	SELL	$18.85 - $27.5 $71,630 - $104,500	-3,800 Reduced 5.32%	67,600 $1.3 Million
Q2 2019 Aug 13, 2019	BUY	$17.37 - $26.27 $1.24 Million - $1.88 Million	71,400 New	71,400 $1.68 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.